FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2.
FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2.
复制标题
DOI:
10.1186/s13046-020-01677-w
复制
发表时间:
2020-09-29
期刊:
影响因子:
--
通讯作者:
Yu Y
中科院分区:
文献类型:
--
作者:
Guo P;Tian Z;Kong X;Yang L;Shan X;Dong B;Ding X;Jing X;Jiang C;Jiang N;Yu Y
Globally, colorectal cancer (CRC) affects more than 1 million people each year. In addition to non-modifiable and other environmental risk factors, Fusobacterium nucleatum infection has been linked to CRC recently. In this study, we explored mechanisms underlying the role of Fusobacterium nucleatum infection in the progression of CRC in a mouse model. C57BL/6 J-Adenomatous polyposis coli (APC) Min/J mice [APC (Min/+)] were treated with Fusobacterium nucleatum (109 cfu/mL, 0.2 mL/time/day, i.g., 12 weeks), saline, or FadA knockout (FadA−/−) Fusobacterium nucleatum. The number, size, and weight of CRC tumors were determined in isolated tumor masses. The human CRC cell lines HCT29 and HT116 were treated with lentiviral vectors overexpressing chk2 or silencing β-catenin. DNA damage was determined by Comet assay and γH2AX immunofluorescence assay and flow cytometry. The mRNA expression of chk2 was determined by RT-qPCR. Protein expression of FadA, E-cadherin, β-catenin, and chk2 were determined by Western blot analysis. Fusobacterium nucleatum treatment promoted DNA damage in CRC in APC (Min/+) mice. Fusobacterium nucleatum also increased the number of CRC cells that were in the S phase of the cell cycle. FadA−/− reduced tumor number, size, and burden in vivo. FadA−/− also reduced DNA damage, cell proliferation, expression of E-cadherin and chk2, and cells in the S phase. Chk2 overexpression elevated DNA damage and tumor growth in APC (Min/+) mice. In conclusion, this study provided evidence that Fusobacterium nucleatum induced DNA damage and cell growth in CRC through FadA-dependent activation of the E-cadherin/β-catenin pathway, leading to up-regulation of chk2.
登录
查看更多内容
DOI:
10.1186/bcr435
发表时间:
2002
期刊:
Breast cancer research : BCR
影响因子:
--
作者:
Ingvarsson S;Sigbjornsdottir BI;Huiping C;Hafsteinsdottir SH;Ragnarsson G;Barkardottir RB;Arason A;Egilsson V;Bergthorsson JT
通讯作者:
Bergthorsson JT
影响因子:
14.9
作者:
Magni M;Ruscica V;Buscemi G;Kim JE;Nachimuthu BT;Fontanella E;Delia D;Zannini L
通讯作者:
Zannini L
影响因子:
12.6
作者:
Boardman, Lisa A.;Morlan, Bruce W.;Gallinger, Steven
通讯作者:
Gallinger, Steven
影响因子:
3.7
作者:
Liu P;Liu Y;Wang J;Guo Y;Zhang Y;Xiao S
通讯作者:
Xiao S
影响因子:
4.3
作者:
Li, Yu-Yuan;Ge, Quan-Xing;Nie, Yu-Qiang
通讯作者:
Nie, Yu-Qiang